생명과학 분석 시장 규모, 점유율, 동향 분석 리포트 : 컴포넌트별, 유형별, 유통별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Life Science Analytics Market Growth & Trends:

The global life science analytics market size is estimated to reach USD 16.33 billion by 2030, registering to grow at a CAGR of 7.50% from 2025 to 2030 according to a new report by Grand View Research, Inc. The growing demand to enhance patient care experience and improve clinical outcomes while minimizing rising healthcare expenses is driving the adoption of analytical solutions in the life sciences market. Social media and improving internet connectivity are significantly impacting the demand for analytical solutions. Emerging trends of the digitalization of healthcare and the growing demand for personalized medicine are contributing to the adoption rates. Furthermore, the adoption of big data analytics and the emergence of advanced data mining techniques are bolstering market growth.

The ongoing Covid-19 pandemic exposed the shortcomings of the existing, overburdened healthcare systems, thus driving the demand for analytical solutions. Key players are rapidly making technological advancements to overcome the existing limitations and identify new verticals for growth. For instance, Moderna implemented IBM analytical solutions integrated with cloud computing, artificial intelligence algorithms, and blockchain solutions to successfully roll out their Covid-19 vaccine program.

The services component segment dominated the market in 2024 owing to the growing trend of outsourcing individual or multi-package services in implementing analytical solutions. Life science organizations lack the required expertise and resources, which drives the outsourcing of services from third-party vendors or consulting firms, which positively impacts the growth of the services segment. The descriptive type of analytical solutions led the market in 2021 owing to the growing implementation of descriptive analysis on historic datasets to analyze the current business scenarios. The predictive type segment is expected to grow lucratively over the forecast period owing to the rising adoption of advanced analytics to predict future outcomes and trends.

The sales and marketing support application segment dominated the market in 2024 owing to the rapid adoption of analytical solutions in sales and marketing functionalities of life science organizations to enhance customer responsiveness and improve engagement to achieve higher sales productivity. The research and development application segment is expected to grow significantly owing to the implementation of analytical solutions in the drug discovery and development process and clinical trial management. The growing product pipeline of life science organizations is contributing to the growth of the research and development segment. The on-demand delivery segment led the market in 2021 and is expected to grow lucratively owing to the rising demand for cloud-deployed and web-hosted analytical solutions with higher ease of access from remotest locations.

The pharmaceutical end-user segment dominated the market in 2024 owing to the rising adoption rates of analytical solutions in improving drug discovery processes and enhancing the efficiency of clinical trials. The biotechnology end-user segment is expected to register the fastest growth rate over the forecast period owing to the adoption of analytical solutions in genome sequencing and analysis. In 2021, North America dominated the market owing to advanced digital literacy, adequate healthcare IT infrastructure, the presence of key players, and high economic development. Asia Pacific is expected to grow lucratively owing to the emergence of startups, favorable funding options, supportive government initiatives, growing healthcare IT expenditure, and the easy availability of high-skilled and low-cost personnel.

Life Science Analytics Market Report Highlights:

• The services segment held the largest revenue share of 57.66% in 2024 and is expected to grow fastest for the forecast period.
• The descriptive analytics segment held the largest revenue share in the market in 2024 due to its crucial role in summarizing historical data and generating actionable insights.
• The sales and marketing support segment held the largest revenue share in 2024 due to its critical role in optimizing product positioning, targeting, and campaign effectiveness.
• The on-demand segment held the largest revenue share in 2024 and is expected to grow at the fastest CAGR for the forecast period.

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Deployment mode
  • 1.1.2. Component
  • 1.1.3. Type
  • 1.1.4. Application
  • 1.1.5. Delivery
  • 1.1.6. End Use
  • 1.1.7. Regional scope
  • 1.1.8. Estimates and forecast timeline.
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Component outlook
  • 2.2.2. Type outlook
  • 2.2.3. Application outlook
  • 2.2.4. Delivery outlook
  • 2.2.5. End use outlook
  • 2.2.6. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Life Science Analytics Market Variables, Trends & Scope

• 3.1. Market Dynamics
  • 3.1.1. Market Driver Analysis
    • 3.1.1.1. Rapid technological advancements
    • 3.1.1.2. Substantial investments by the healthcare industry in IT development and digitization
    • 3.1.1.3. Increased government initiative
    • 3.1.1.4. Clinical effectiveness and patient satisfaction
    • 3.1.1.5. Financial and administrative performance
    • 3.1.1.6. Operational effectiveness
  • 3.1.2. Market Restraint Analysis
  • 3.1.3. Market Challenges Analysis
  • 3.1.4. Market Opportunities Analysis
• 3.2. Life Science Analytics Market Analysis Tools
  • 3.2.1. Industry Analysis - Porter's
    • 3.2.1.1. Supplier power
    • 3.2.1.2. Buyer power
    • 3.2.1.3. Substitution threat
    • 3.2.1.4. Threat of new entrant
    • 3.2.1.5. Competitive rivalry
  • 3.2.2. PESTEL Analysis
    • 3.2.2.1. Political landscape
    • 3.2.2.2. Economic landscape
    • 3.2.2.3. Social landscape
    • 3.2.2.4. Technological landscape
    • 3.2.2.5. Environmental landscape
    • 3.2.2.6. Legal landscape
• 3.3. Regulatory Framework
• 3.4. Emerging Technology
• 3.5. Impact of COVID 19 on life science analytics market
• 3.6. Case Studies & Insights

Chapter 4. Life Science Analytics Market: Component Estimates & Trend Analysis

• 4.1. Component Market Share, 2024 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Life Science Analytics Market By Component Outlook
• 4.4. Software
  • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Services
  • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Life Science Analytics Market: Type Estimates & Trend Analysis

• 5.1. Type Market Share, 2024 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Life Science Analytics Market By Type Outlook
• 5.4. Reporting
  • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.5. Descriptive
  • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.6. Predictive
  • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.7. Prescriptive
  • 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Life Science Analytics Market: Application Estimates & Trend Analysis

• 6.1. Application Market Share, 2024 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Life Science Analytics Market By Application Outlook
• 6.4. Research and Development
  • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.5. Sales and Marketing Support
  • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.6. Regulatory Compliance
  • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.7. Supply Chain Analytics
  • 6.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.8. Pharmacovigilance
  • 6.8.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Life Science Analytics Market: Delivery Estimates & Trend Analysis

• 7.1. Delivery Market Share, 2024 & 2030
• 7.2. Segment Dashboard
• 7.3. Global Life Science Analytics Market By Delivery Outlook
• 7.4. On-Demand
  • 7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 7.5. On-Premises
  • 7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Life Science Analytics Market: End Use Estimates & Trend Analysis

• 8.1. End Use Market Share, 2024 & 2030
• 8.2. Segment Dashboard
• 8.3. Global Life Science Analytics Market By End Use Outlook
• 8.4. Medical Devices
  • 8.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 8.5. Pharmaceutical
  • 8.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 8.6. Biotechnology
  • 8.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 8.7. Genomics
  • 8.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 8.8. Others
  • 8.8.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 9. Life Science Analytics Market: Regional Estimates & Trend Analysis, By Component, Type, Application, Delivery, and End Use

• 9.1. Regional Market Share Analysis, 2024 & 2030
• 9.2. Regional Market Dashboard
• 9.3. Global Regional Market Snapshot
• 9.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 9.5. North America
  • 9.5.1. U.S.
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Regulatory framework
    • 9.5.1.3. Competitive scenario
    • 9.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.2. Canada
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework
    • 9.5.2.3. Competitive scenario
    • 9.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.3. Mexico
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory framework
    • 9.5.3.3. Competitive scenario
    • 9.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 9.6. Europe
  • 9.6.1. UK
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Regulatory framework
    • 9.6.1.3. Competitive scenario
    • 9.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.2. Germany
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.3. France
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Regulatory framework
    • 9.6.3.3. Competitive scenario
    • 9.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.4. Italy
    • 9.6.4.1. Key country dynamics
    • 9.6.4.2. Regulatory framework
    • 9.6.4.3. Competitive scenario
    • 9.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.5. Spain
    • 9.6.5.1. Key country dynamics
    • 9.6.5.2. Regulatory framework
    • 9.6.5.3. Competitive scenario
    • 9.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.6. Norway
    • 9.6.6.1. Key country dynamics
    • 9.6.6.2. Regulatory framework
    • 9.6.6.3. Competitive scenario
    • 9.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.7. Sweden
    • 9.6.7.1. Key country dynamics
    • 9.6.7.2. Regulatory framework
    • 9.6.7.3. Competitive scenario
    • 9.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.8. Denmark
    • 9.6.8.1. Key country dynamics
    • 9.6.8.2. Regulatory framework
    • 9.6.8.3. Competitive scenario
    • 9.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 9.7. Asia Pacific
  • 9.7.1. Japan
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Regulatory framework
    • 9.7.1.3. Competitive scenario
    • 9.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.2. China
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory framework
    • 9.7.2.3. Competitive scenario
    • 9.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.3. India
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Regulatory framework
    • 9.7.3.3. Competitive scenario
    • 9.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.4. Australia
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Regulatory framework
    • 9.7.4.3. Competitive scenario
    • 9.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.5. South Korea
    • 9.7.5.1. Key country dynamics
    • 9.7.5.2. Regulatory framework
    • 9.7.5.3. Competitive scenario
    • 9.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.6. Thailand
    • 9.7.6.1. Key country dynamics
    • 9.7.6.2. Regulatory framework
    • 9.7.6.3. Competitive scenario
    • 9.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
• 9.8. Latin America
  • 9.8.1. Brazil
    • 9.8.1.1. Key country dynamics
    • 9.8.1.2. Regulatory framework
    • 9.8.1.3. Competitive scenario
    • 9.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.2. Argentina
    • 9.8.2.1. Key country dynamics
    • 9.8.2.2. Regulatory framework
    • 9.8.2.3. Competitive scenario
    • 9.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 9.9. MEA
  • 9.9.1. South Africa
    • 9.9.1.1. Key country dynamics
    • 9.9.1.2. Regulatory framework
    • 9.9.1.3. Competitive scenario
    • 9.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.2. Saudi Arabia
    • 9.9.2.1. Key country dynamics
    • 9.9.2.2. Regulatory framework
    • 9.9.2.3. Competitive scenario
    • 9.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.3. UAE
    • 9.9.3.1. Key country dynamics
    • 9.9.3.2. Regulatory framework
    • 9.9.3.3. Competitive scenario
    • 9.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.4. Kuwait
    • 9.9.4.1. Key country dynamics
    • 9.9.4.2. Regulatory framework
    • 9.9.4.3. Competitive scenario
    • 9.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Company/Competition Categorization
• 10.3. Key company market share/position analysis, 2024
• 10.4. Company Profiles
  • 10.4.1. Oracle
    • 10.4.1.1. Company overview
    • 10.4.1.2. Financial performance
    • 10.4.1.3. Technology Type benchmarking
    • 10.4.1.4. Strategic initiatives
  • 10.4.2. IQVIA
    • 10.4.2.1. Company overview
    • 10.4.2.2. Financial performance
    • 10.4.2.3. Technology Type benchmarking
    • 10.4.2.4. Strategic initiatives
  • 10.4.3. SAS Institute Inc.
    • 10.4.3.1. Company overview
    • 10.4.3.2. Financial performance
    • 10.4.3.3. Technology Type benchmarking
    • 10.4.3.4. Strategic initiatives
  • 10.4.4. Cognizant
    • 10.4.4.1. Company overview
    • 10.4.4.2. Financial performance
    • 10.4.4.3. Technology Type benchmarking
    • 10.4.4.4. Strategic initiatives
  • 10.4.5. IBM
    • 10.4.5.1. Company overview
    • 10.4.5.2. Financial performance
    • 10.4.5.3. Technology Type benchmarking
    • 10.4.5.4. Strategic initiatives
  • 10.4.6. Accenture
    • 10.4.6.1. Company overview
    • 10.4.6.2. Financial performance
    • 10.4.6.3. Technology Type benchmarking
    • 10.4.6.4. Strategic initiatives
  • 10.4.7. Take Solutions Limited
    • 10.4.7.1. Company overview
    • 10.4.7.2. Financial performance
    • 10.4.7.3. Technology Type benchmarking
    • 10.4.7.4. Strategic initiatives
  • 10.4.8. Wipro Limited
    • 10.4.8.1. Company overview
    • 10.4.8.2. Financial performance
    • 10.4.8.3. Technology Type benchmarking
    • 10.4.8.4. Strategic initiatives
  • 10.4.9. Veradigm
    • 10.4.9.1. Company overview
    • 10.4.9.2. Financial performance
    • 10.4.9.3. Technology Type benchmarking
    • 10.4.9.4. Strategic initiatives
  • 10.4.10. Optum
    • 10.4.10.1. Company overview
    • 10.4.10.2. Financial performance
    • 10.4.10.3. Technology Type benchmarking
    • 10.4.10.4. Strategic initiatives
  • 10.4.11. Veeva Systems
    • 10.4.11.1. Company overview
    • 10.4.11.2. Financial performance
    • 10.4.11.3. Technology Type benchmarking
    • 10.4.11.4. Strategic initiatives
  • 10.4.12. Axtria
    • 10.4.12.1. Company overview
    • 10.4.12.2. Financial performance
    • 10.4.12.3. Technology Type benchmarking
    • 10.4.12.4. Strategic initiatives
  • 10.4.13. Komoda Health, Inc.
    • 10.4.13.1. Company overview
    • 10.4.13.2. Financial performance
    • 10.4.13.3. Technology Type benchmarking
    • 10.4.13.4. Strategic initiatives
  • 10.4.14. Elsevier
    • 10.4.14.1. Company overview
    • 10.4.14.2. Financial performance
    • 10.4.14.3. Technology Type benchmarking
    • 10.4.14.4. Strategic initiatives